Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models.
Cancer Sci
; 105(10): 1334-42, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-25060424
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Tubulin Modulators
/
Tumor Microenvironment
/
Vascular Remodeling
/
Furans
/
Ketones
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Sci
Year:
2014
Document type:
Article
Affiliation country:
Estados Unidos